http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0141784-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0878d21971b8ffbccb5657a9303e4c28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57d51243d8c36c2914f88e65ffe86f54
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
filingDate 2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b16b6e59c2b5526c24ae5ad3a768541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a53f219f7bf4468c6ea6c5d989668a2
publicationDate 2001-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0141784-A1
titleOfInvention Methods and compositions for use in the treatment of filovirus mediated disease conditions
abstract Methods and compositions are provided for at least slowing the progression of a filovirus mediated disease condition in a host. In the subject methods, an effective amount of an agent that at least reduces the amount of folate receptor mediated filovirus cell entry is administered to the host. The subject methods find use in both the prevention and treatment of filovirus associated disease conditions, including Marburg and Ebola-Zaire virus mediated disease conditions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008156853-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008156853-A2
priorityDate 1999-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5447851-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5416016-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5447851-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6093382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837533-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135415876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136262340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135805228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226453780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135770420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136144480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129928536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129093514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548

Total number of triples: 73.